U.S. federal trademark · Serial No. 98349160 · Reg. No. 40202400528T
Research and development in the fields of pharmaceuticals, genetics, therapeutics, and drug formulation and delivery; scientific research; scientific research in the fields of pharmaceuticals, medicine, and nucleic acid therapeutics; research, development, and testing services in the field of nucleic acid therapeutics for medical and scientific applications; medical research; laboratory research services relating to pharmaceuticals
Nucleic acid sequences and chemical reagents for medical purposes; pharmaceutical preparations for the treatment of genetic diseases and disorders; genetic medicines for the treatment of diseases and disorders with known genetic cause, component and disease states resulting from gene expression and genetic sequence; nucleic acid therapeutic agents for the treatment of Huntington's disease, Duchenne muscular dystrophy, and alpha-1 antitrypsin deficiency for medical purposes; pharmaceutical preparations for the prevention, diagnosis, and treatment of metabolic, cardiometabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, renal, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, neurodegenerative, gastrointestinal, hormonal, inflammatory, dermatological, psychiatric, autoimmune, and immune system related diseases and disorders
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.